Show simple item record

dc.contributor.authorLokken, Erica M
dc.contributor.authorMandaliya, Kishorchandra
dc.contributor.authorSrinivasan, Sujatha
dc.contributor.authorRichardson, Barbra A
dc.contributor.authorKinuthia, John
dc.contributor.authorLannon, Sophia
dc.contributor.authorJaoko, Walter
dc.contributor.authorAlumera, Hudson
dc.contributor.authorKemoli, Arthur
dc.contributor.authorFay, Emily
dc.contributor.authorJohn-Stewart, G
dc.contributor.authorFredricks, David N
dc.date.accessioned2021-01-18T12:28:10Z
dc.date.available2021-01-18T12:28:10Z
dc.date.issued2020
dc.identifier.citationLokken EM, Mandaliya K, Srinivasan S, Richardson BA, Kinuthia J, Lannon S, Jaoko W, Alumera H, Kemoli A, Fay E, John-Stewart G, Fredricks DN, McClelland RS. Impact of preconception vaginal microbiota on women's risk of spontaneous preterm birth: protocol for a prospective case-cohort study. BMJ Open. 2020 Feb 25;10(2):e035186. doi: 10.1136/bmjopen-2019-035186. PMID: 32102825; PMCID: PMC7045118.en_US
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/32102825/
dc.identifier.urihttp://erepository.uonbi.ac.ke/handle/11295/153616
dc.description.abstractIntroduction: Bacterial vaginosis (BV) and vaginal microbiota disruption during pregnancy are associated with increased risk of spontaneous preterm birth (SPTB), but clinical trials of BV treatment during pregnancy have shown little or no benefit. An alternative hypothesis is that vaginal bacteria present around conception may lead to SPTB by compromising the protective effects of cervical mucus, colonising the endometrial surface before fetal membrane development, and causing low-level inflammation in the decidua, placenta and fetal membranes. This protocol describes a prospective case-cohort study addressing this hypothesis. Methods and analysis: HIV-seronegative Kenyan women with fertility intent are followed from preconception through pregnancy, delivery and early postpartum. Participants provide monthly vaginal specimens during the preconception period for vaginal microbiota assessment. Estimated date of delivery is determined by last menstrual period and first trimester obstetrical ultrasound. After delivery, a swab is collected from between the fetal membranes. Placenta and umbilical cord samples are collected for histopathology. Broad-range 16S rRNA gene PCR and deep sequencing of preconception vaginal specimens will assess species richness and diversity in women with SPTB versus term delivery. Concentrations of key bacterial species will be compared using quantitative PCR (qPCR). Taxon-directed qPCR will also be used to quantify bacteria from fetal membrane samples and evaluate the association between bacterial concentrations and histopathological evidence of inflammation in the fetal membranes, placenta and umbilical cord. Ethics and dissemination: This study was approved by ethics committees at Kenyatta National Hospital and the University of Washington. Results will be disseminated to clinicians at study sites and partner institutions, presented at conferences and published in peer-reviewed journals. The findings of this study could shift the paradigm for thinking about the mechanisms linking vaginal microbiota and prematurity by focusing attention on the preconception vaginal microbiota as a mediator of SPTB.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectepidemiology; microbiology; obstetrics.en_US
dc.titleImpact of preconception vaginal microbiota on women's risk of spontaneous preterm birth: protocol for a prospective case-cohort studyen_US
dc.typeArticleen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States